SCHEMBL29316595

SCHEMBL29316595

C=C(C)C1CCN(C2CCCNC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.49
SLC6A1 P30531 2/20 0.34
SLC6A11 P48066 1/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC6A13 Q9NSD5 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
NOS2 P35228 1/20 0.33
CYP2D6 P10635 1/20 0.33
RAB9A P51151 1/20 0.32
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR2B P41595 1/20 0.31
HTR3A P46098 1/20 0.31
TMEM97 Q5BJF2 1/20 0.31
HTR3D Q70Z44 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5228670 0.77 HTR6 (0.57) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20757788 0.77 HTR6 (0.57) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20757771 0.77 HTR6 (0.57) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20744481 0.76 HTR6 (0.72) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL12730878 0.76 HTR6 (0.72) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20744604 0.76 HTR6 (0.79) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL2328636 0.76 HTR6 (0.79) HTR6SLC6A1SLC6A11TSHRLMNA
Hydrochloric Acid SCHEMBL31015226 0.75 HTR6 (0.55) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20757922 0.74 HTR6 (0.59) HTR6SLC6A1SLC6A11TSHRLMNA
SCHEMBL20757921 0.74 HTR6 (0.59) HTR6SLC6A1SLC6A11TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed